 |
aztreonam |
|---|---|
| Trade Name | Cayston |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2002-03-12 00:00:00 |
| Sponsor | Gilead Sciences (formerly Corus Pharma);199 East Blaine St;Seattle, Washington, 98102 |
Related Access Program
| |
aztreonam |
|---|---|
| Trade Name | Cayston |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2002-03-12 00:00:00 |
| Sponsor | Gilead Sciences (formerly Corus Pharma);199 East Blaine St;Seattle, Washington, 98102 |